Discover the latest press releases from Crohn's & Colitis Foundation with the Atlanta Business Chronicle's BizSpotlight ...

A man from Cardiff who spent a year in hospital with an incurable bowel disease is now running his own business and embarking ...

MRM Health has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) ...

While many people have heard of the illnesses Crohn’s disease and ulcerative colitis, most are probably not aware that New ...

French newspaper La Lettre said the Paris-based biotech – which is listed on the Nasdaq – has been on Lilly's radar after ...

Abivax (ABVX) stays a Buy as obefazimod UC data fuels multi‑billion potential; 2026 Phase 3/NDA catalysts loom and M&A ...

Mirador Therapeutics, Inc. (Mirador), a clinical-stage precision medicine company developing next-generation therapies for ...

Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of first patient first dose in BETHESDA: a Phase IIa clinical trial of ...

Shares in Abivax jumped sharply on Monday after a report said U.S. drugmaker Eli Lilly remains interested in acquiring the French biotech.

Mariana Tata experienced a few subtle, common symptoms of colon cancer and got them checked out. She was diagnosed at stage 4 ...

France's Finance Ministry refutes reports of Eli Lilly's intent to acquire French biotech Abivax for €15 billion. Abivax shares spiked following the rumors but receded after the Ministry's denial.

AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...